Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
Song KR, Chapagain RH, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S, Wartel TA, Yang JS, Kim DR, Lee J, Park EL, Cho H, Lee J, Thaisrivichai P, Vemula S, Kim BM, Gupta B, Saluja T, Pansuriya RK, Ganapathy R, Baik YO, Lee YJ, Jeon S, Park Y, Her HL, Park Y, Lynch JA. Song KR, et al. Among authors: baik yo. Lancet Glob Health. 2024 May;12(5):e826-e837. doi: 10.1016/S2214-109X(24)00059-7. Lancet Glob Health. 2024. PMID: 38614631 Free PMC article. Clinical Trial.
Do some prefer to pay? Identifying bias against free COVID-19 tests.
Baik Y, Bien-Gund CH, Bisson GP, Gross R, Fishman J. Baik Y, et al. Public Health Pract (Oxf). 2024 Feb 27;7:100483. doi: 10.1016/j.puhip.2024.100483. eCollection 2024 Jun. Public Health Pract (Oxf). 2024. PMID: 38449769 Free PMC article.
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Semitala FC, Kadota JL, Musinguzi A, Welishe F, Nakitende A, Akello L, Kunihira Tinka L, Nakimuli J, Ritar Kasidi J, Bishop O, Nakasendwa S, Baik Y, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A. Semitala FC, et al. Among authors: baik y. PLoS Med. 2024 Feb 20;21(2):e1004356. doi: 10.1371/journal.pmed.1004356. eCollection 2024 Feb. PLoS Med. 2024. PMID: 38377166 Free PMC article. Clinical Trial.
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial.
Shah S, Nandy RK, Sethi SS, Chavan B, Pathak S, Dutta S, Rai S, Singh C, Chayal V, Patel C, Kumar NR, Chavan AT, Chawla A, Singh A, Roy AK, Singh N, Baik YO, Lee Y, Park Y, Jeong KH, Ahmed S. Shah S, et al. Among authors: baik yo. Lancet Reg Health Southeast Asia. 2023 Aug 24;19:100256. doi: 10.1016/j.lansea.2023.100256. eCollection 2023 Dec. Lancet Reg Health Southeast Asia. 2023. PMID: 38076719 Free PMC article.
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects.
Lovell JF, Miura K, Baik YO, Lee C, Lee JY, Park YS, Hong I, Lee JH, Kim T, Seo SH, Kim JO, Song M, Kim CJ, Choi JK, Kim J, Choo EJ, Choi JH. Lovell JF, et al. Among authors: baik yo. Int J Infect Dis. 2024 Jan;138:73-80. doi: 10.1016/j.ijid.2023.11.004. Epub 2023 Nov 7. Int J Infect Dis. 2024. PMID: 37944586 Free article.
Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor.
Park H, Kim HJ, Sohn SK, Baik Y, Kim D, Lee SY, Kong JH, Kim H, Shin DY, Ahn JS, Park J, Park S, Kim I. Park H, et al. Among authors: baik y. Ther Adv Hematol. 2023 Nov 2;14:20406207231205637. doi: 10.1177/20406207231205637. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37929079 Free PMC article.
101 results